Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Metodi V. Stankov"'
Autor:
Lu Zhang, Alexandra Dopfer-Jablonka, Anne Cossmann, Metodi V. Stankov, Luise Graichen, Anna-Sophie Moldenhauer, Christina Fichter, Anupriya Aggarwal, Stuart G. Turville, Georg M.N. Behrens, Stefan Pöhlmann, Markus Hoffmann
Publikováno v:
iScience, Vol 27, Iss 6, Pp 109904- (2024)
Summary: In July/August 2023, the highly mutated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BA.2.86 lineage emerged and its descendant JN.1 is on track to become the dominant SARS-CoV-2 lineage globally. Compared to the spike (S) pr
Externí odkaz:
https://doaj.org/article/9a612668a4d24632b6397b7efee5269e
Autor:
Ivan Odak, Lennart Riemann, Inga Sandrock, Anne Cossmann, Gema Morillas Ramos, Swantje I. Hammerschmidt, Christiane Ritter, Michaela Friedrichsen, Ahmed Hassan, Alexandra Dopfer-Jablonka, Metodi V. Stankov, Leonie M. Weskamm, Marylyn M. Addo, Inga Ravens, Stefanie Willenzon, Anja Schimrock, Jasmin Ristenpart, Anika Janssen, Joana Barros-Martins, Gesine Hansen, Christine Falk, Georg M.N. Behrens, Reinhold Förster
Publikováno v:
EBioMedicine, Vol 99, Iss , Pp 104947- (2024)
Summary: Background: Human immune responses to COVID-19 vaccines display a large heterogeneity of induced immunity and the underlying immune mechanisms for this remain largely unknown. Methods: Using a systems biology approach, we longitudinally prof
Externí odkaz:
https://doaj.org/article/dc942db6e492430cafa301d2bcc525b7
Autor:
Lu Zhang, Alexandra Dopfer-Jablonka, Inga Nehlmeier, Amy Kempf, Luise Graichen, Noemí Calderón Hampel, Anne Cossmann, Metodi V. Stankov, Gema Morillas Ramos, Sebastian R. Schulz, Hans-Martin Jäck, Georg M. N. Behrens, Stefan Pöhlmann, Markus Hoffmann
Publikováno v:
Vaccines, Vol 12, Iss 5, p 487 (2024)
Transmissibility and immune evasion of the recently emerged, highly mutated SARS-CoV-2 BA.2.87.1 are unknown. Here, we report that BA.2.87.1 efficiently enters human cells but is more sensitive to antibody-mediated neutralization than the currently d
Externí odkaz:
https://doaj.org/article/cd69a4083c014053bc288930db5d3c65
Autor:
Georg M. N. Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi V. Stankov, Ivan Odak, Alexandra Dopfer-Jablonka, Laura Hetzel, Miriam Köhler, Gwendolyn Patzer, Christoph Binz, Christiane Ritter, Michaela Friedrichsen, Christian Schultze-Florey, Inga Ravens, Stefanie Willenzon, Anja Bubke, Jasmin Ristenpart, Anika Janssen, George Ssebyatika, Verena Krähling, Günter Bernhardt, Markus Hoffmann, Stefan Pöhlmann, Thomas Krey, Berislav Bošnjak, Swantje I. Hammerschmidt, Reinhold Förster
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Vaccines against SARS-CoV-2 have changed the course of the COVID-19 pandemics, but waning immunity necessitates repeated immunization. Authors here show that immunity declines faster following two doses of vector-based vaccine compared to a first dos
Externí odkaz:
https://doaj.org/article/f52b7c9a5c1744e8b2ee862e712fdd80
Autor:
Joana Barros-Martins, Swantje I. Hammerschmidt, Gema Morillas Ramos, Anne Cossmann, Laura Hetzel, Ivan Odak, Miriam Köhler, Metodi V. Stankov, Christiane Ritter, Michaela Friedrichsen, Inga Ravens, Anja Schimrock, Jasmin Ristenpart, Anika Janssen, Stefanie Willenzon, Günter Bernhardt, Ralf Lichtinghagen, Berislav Bošnjak, Georg M. N. Behrens, Reinhold Förster
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Since early 2022, various Omicron variants have dominated the SARS-CoV-2 pandemic in most countries. All Omicron variants are B-cell immune escape variants, and antibodies induced by first-generation COVID-19 vaccines or by infection with earlier SAR
Externí odkaz:
https://doaj.org/article/11b381854c5e4bc19005652544e278a1
Autor:
Alexandra Dopfer-Jablonka, Sandra Steffens, Frank Müller, Marie Mikuteit, Jacqueline Niewolik, Anne Cossmann, Metodi V. Stankov, Georg M. N. Behrens, Eva Hummers, Gloria Heesen, Dominik Schröder, Sascha Roder, Frank Klawonn, Kai Vahldiek, Justin Hasenkamp, Jonathan Kallusky, Christine S. Falk, Tobias R. Overbeck, Stephanie Heinemann
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Immunocompromised people (ICP) and elderly individuals (older than 80 years) are at increased risk for severe coronavirus infections. To protect against serious infection with SARS-CoV-2, ICP are taking precautions that may includ
Externí odkaz:
https://doaj.org/article/29e8ea9c8af64537872d10a5de524008
Autor:
Alex Dulovic, Monika Strengert, Gema Morillas Ramos, Matthias Becker, Johanna Griesbaum, Daniel Junker, Karsten Lürken, Andrea Beigel, Eike Wrenger, Gerhard Lonnemann, Anne Cossmann, Metodi V. Stankov, Alexandra Dopfer-Jablonka, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Gérard Krause, Nicole Schneiderhan-Marra, Georg M.N. Behrens
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 4, Pp 743-750 (2022)
Patients undergoing chronic hemodialysis were among the first to receive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations because of their increased risk for severe coronavirus disease and high case-fatality rates. By using a
Externí odkaz:
https://doaj.org/article/bf1f2ba9a9164267856bf376d78e8a99
Autor:
Matthias Becker, Anne Cossmann, Karsten Lürken, Daniel Junker, Jens Gruber, Jennifer Juengling, Gema Morillas Ramos, Andrea Beigel, Eike Wrenger, Gerhard Lonnemann, Metodi V. Stankov, Alexandra Dopfer-Jablonka, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Gérard Krause, Nicole Schneiderhan-Marra, Monika Strengert, Alex Dulovic, Georg M. N. Behrens
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Haemodialysis patients respond poorly to vaccination and continue to be at-risk for severe COVID-19. Therefore, dialysis patients were among the first for which a fourth COVID-19 vaccination was recommended. However, targeted information on how to be
Externí odkaz:
https://doaj.org/article/c3c8a3ec127e47309ad52458e675fb17
Autor:
Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Martin S. Winkler, Martin Lier, Sebastian Schulz, Hans-Martin Jäck, Anne Cossmann, Metodi V. Stankov, Georg M.N. Behrens, Stefan Pöhlmann, Markus Hoffmann
Publikováno v:
Cell Reports, Vol 39, Iss 5, Pp 110754- (2022)
Summary: Rapid spread of SARS-CoV-2 variants C.1.2 and B.1.621 (Mu variant) in Africa and the Americas, respectively, as well as a high number of mutations in the viral spike proteins raised concerns that these variants might pose an elevated threat
Externí odkaz:
https://doaj.org/article/1fb852d0d9bb437db843675916e4b705
Autor:
Ivan Odak, Christian R. Schultze-Florey, Swantje I. Hammerschmidt, Christiane Ritter, Stefanie Willenzon, Michaela Friedrichsen, Inga Ravens, Ruth Sikora, Lâle M. Bayir, Rodrigo Gutierrez Jauregui, Günter Bernhardt, Metodi V. Stankov, Anne Cossmann, Guido Hansen, Thomas Krey, Markus Cornberg, Christian Koenecke, Georg M. N. Behrens, Berislav Bošnjak, Reinhold Förster
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Evaluating long-term protection against SARS-CoV-2 variants of concern in convalescing individuals is of high clinical relevance. In this prospective study of a cohort of 46 SARS-CoV-2 patients infected with the Wuhan strain of SARS-CoV-2 we longitud
Externí odkaz:
https://doaj.org/article/cf4df2c823ac4cc7985e44f248684b3b